LIMB GIRDLE MUSCULAR DYSTROPHY
Clinical trials for LIMB GIRDLE MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LIMB GIRDLE MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for LIMB GIRDLE MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial offers hope for rare muscle disease
Disease control Recruiting nowThis study tests a single dose of a gene therapy called AB-1003 in 10 adults with a rare genetic muscle disease (LGMD2I/R9). The goal is to see if it is safe and can help improve muscle function. Participants must be able to walk or run 10 meters in under 30 seconds.
Matched conditions: LIMB GIRDLE MUSCULAR DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Virtual group therapy aims to boost social skills in kids with rare muscle disease
Symptom relief Recruiting nowThis trial tests a 12-session telecare program for children aged 7 to 17 with limb-girdle muscular dystrophy. The group-based intervention focuses on social cognition, emotional management, and coping strategies to improve quality of life and reduce symptoms. Participants attend …
Matched conditions: LIMB GIRDLE MUSCULAR DYSTROPHY
Phase: NA • Sponsor: University of Deusto • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC